Skip to main content

Published locations for FDA approves first gene therapy, betibeglogene autotemcel (Zynteglo), for beta-thalassemia

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves first gene therapy, betibeglogene autotemcel (Zynteglo), for beta-thalassemia

User login

  • Reset your password
  • /content/fda-approves-first-gene-therapy-betibeglogene-autotemcel-zynteglo-beta-thalassemia
  • /familypracticenews/article/257107/transfusion-medicine/fda-approves-first-gene-therapy-betibeglogene
  • /hematologynews/article/257107/transfusion-medicine/fda-approves-first-gene-therapy-betibeglogene
  • /internalmedicinenews/article/257107/transfusion-medicine/fda-approves-first-gene-therapy
  • /pediatricnews/article/257107/transfusion-medicine/fda-approves-first-gene-therapy-betibeglogene
  • /hematology-oncology/article/257107/transfusion-medicine/fda-approves-first-gene-therapy
  • /pediatrics/article/257107/transfusion-medicine/fda-approves-first-gene-therapy-betibeglogene
  • /internalmedicine/article/257107/transfusion-medicine/fda-approves-first-gene-therapy-betibeglogene
  • /familymedicine/article/257107/transfusion-medicine/fda-approves-first-gene-therapy-betibeglogene